(Q77183363)
Statements
Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants (English)
1 September 1998
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference